Expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinoma

ABSTRACT Gene expression of CDKN1A, CDKN1B, and TP53, and immunostaining of p21, p27 and p53 were evaluated to verify the role of these cell cycle inhibitors in canine prostates with proliferative inflammatory atrophy-PIA and prostatic carcinoma-PC. Seventy samples, 15 normal, 30PIA and 25PC. Regard...

Full description

Bibliographic Details
Main Authors: M.B.R. Faleiro, L.C. Cintra, R.S.A. Jesuino, A.D. Damasceno, V.M.B.D. Moura
Format: Article
Language:English
Published: Universidade Federal de Minas Gerais
Series:Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352018000100082&lng=en&tlng=en
_version_ 1811269926821822464
author M.B.R. Faleiro
L.C. Cintra
R.S.A. Jesuino
A.D. Damasceno
V.M.B.D. Moura
author_facet M.B.R. Faleiro
L.C. Cintra
R.S.A. Jesuino
A.D. Damasceno
V.M.B.D. Moura
author_sort M.B.R. Faleiro
collection DOAJ
description ABSTRACT Gene expression of CDKN1A, CDKN1B, and TP53, and immunostaining of p21, p27 and p53 were evaluated to verify the role of these cell cycle inhibitors in canine prostates with proliferative inflammatory atrophy-PIA and prostatic carcinoma-PC. Seventy samples, 15 normal, 30PIA and 25PC. Regarding number of p27 and p53 labeled cells, difference between normal and PIA and PC was observed, as well as between PIA and PC for p53. Immunostaining intensities of p21, p27 and p53 were different when comparing normal tissues to PIA and PC. Sixteen cDNA of canine prostatic FFPE tissue were subjected to RT-PCR and RT-qPCR, four normal, three PIA, and nine PC. CDKN1A mRNA was detected in four PC by RT-PCR, and it was overexpressed when compared to normal by RT-qPCR, in one PIA and six PC. CDKN1B mRNA was detected in three PC by RT-PCR and it was overexpressed in three PC and decreased in one PC. TP53 mRNA was overexpressed in one PIA and three PC. In conclusion, when overexpressed in canine prostate with premalignant and malignant, p21 and p27 play a role controlling cell proliferation, working as a protective factor in the evolution of PIA to PC, and in the PC development, even in the presence of altered p53.
first_indexed 2024-04-12T21:51:50Z
format Article
id doaj.art-55ddc9a786d94afb8d246b9e50725324
institution Directory Open Access Journal
issn 1678-4162
language English
last_indexed 2024-04-12T21:51:50Z
publisher Universidade Federal de Minas Gerais
record_format Article
series Arquivo Brasileiro de Medicina Veterinária e Zootecnia
spelling doaj.art-55ddc9a786d94afb8d246b9e507253242022-12-22T03:15:28ZengUniversidade Federal de Minas GeraisArquivo Brasileiro de Medicina Veterinária e Zootecnia1678-4162701829210.1590/1678-4162-9472S0102-09352018000100082Expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinomaM.B.R. FaleiroL.C. CintraR.S.A. JesuinoA.D. DamascenoV.M.B.D. MouraABSTRACT Gene expression of CDKN1A, CDKN1B, and TP53, and immunostaining of p21, p27 and p53 were evaluated to verify the role of these cell cycle inhibitors in canine prostates with proliferative inflammatory atrophy-PIA and prostatic carcinoma-PC. Seventy samples, 15 normal, 30PIA and 25PC. Regarding number of p27 and p53 labeled cells, difference between normal and PIA and PC was observed, as well as between PIA and PC for p53. Immunostaining intensities of p21, p27 and p53 were different when comparing normal tissues to PIA and PC. Sixteen cDNA of canine prostatic FFPE tissue were subjected to RT-PCR and RT-qPCR, four normal, three PIA, and nine PC. CDKN1A mRNA was detected in four PC by RT-PCR, and it was overexpressed when compared to normal by RT-qPCR, in one PIA and six PC. CDKN1B mRNA was detected in three PC by RT-PCR and it was overexpressed in three PC and decreased in one PC. TP53 mRNA was overexpressed in one PIA and three PC. In conclusion, when overexpressed in canine prostate with premalignant and malignant, p21 and p27 play a role controlling cell proliferation, working as a protective factor in the evolution of PIA to PC, and in the PC development, even in the presence of altered p53.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352018000100082&lng=en&tlng=enp21p27p53PIART-qPCR
spellingShingle M.B.R. Faleiro
L.C. Cintra
R.S.A. Jesuino
A.D. Damasceno
V.M.B.D. Moura
Expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinoma
Arquivo Brasileiro de Medicina Veterinária e Zootecnia
p21
p27
p53
PIA
RT-qPCR
title Expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinoma
title_full Expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinoma
title_fullStr Expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinoma
title_full_unstemmed Expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinoma
title_short Expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinoma
title_sort expression of cell cycle inhibitors in canine prostate with proliferative inflammatory atrophy and carcinoma
topic p21
p27
p53
PIA
RT-qPCR
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352018000100082&lng=en&tlng=en
work_keys_str_mv AT mbrfaleiro expressionofcellcycleinhibitorsincanineprostatewithproliferativeinflammatoryatrophyandcarcinoma
AT lccintra expressionofcellcycleinhibitorsincanineprostatewithproliferativeinflammatoryatrophyandcarcinoma
AT rsajesuino expressionofcellcycleinhibitorsincanineprostatewithproliferativeinflammatoryatrophyandcarcinoma
AT addamasceno expressionofcellcycleinhibitorsincanineprostatewithproliferativeinflammatoryatrophyandcarcinoma
AT vmbdmoura expressionofcellcycleinhibitorsincanineprostatewithproliferativeinflammatoryatrophyandcarcinoma